Back
NovoCure Vs. Perficient Industry Stock Comparison
Buy
58
NVCR
NovoCure
Last Price:
22.01
Seasonality Move:
12.1%
Buy
69
PRFT
Perficient
Last Price:
73.61
Seasonality Move:
-0.36%
Buy
58
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $21.99. The Score for NVCR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Perficient (PRFT)
is a Buy
Is Perficient a Buy, Sell or Hold?
- The current Perficient [PRFT] share price is $73.63. The Score for PRFT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- PRFT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVCR Stock Price Chart
PRFT Stock Price Chart
What is Perficient's stock price today?
-
The Perficient share price today is $73.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRFT is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2 | Buy |
| Relative Strength Index (14 RSI): | 84.57 | Buy |
| Chaikin Money Flow: | 280430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.59 - 18.21) | Buy |
| Bollinger Bands (100): | (12.84 - 16.62) | Buy |
PRFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.3 | Buy |
| Relative Strength Index (14 RSI): | 78.91 | Buy |
| Chaikin Money Flow: | -733734 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.95 - 70.51) | Buy |
| Bollinger Bands (100): | (52.78 - 71.36) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.02 | Buy |
| 20-day SMA: | 15.55 | Buy |
| 50-day SMA: | 14.64 | Buy |
| 200-day SMA: | 16.14 | Buy |
| 8-day EMA: | 19.48 | Buy |
| 20-day EMA: | 16.9 | Buy |
| 50-day EMA: | 15.36 | Buy |
| 200-day EMA: | 21.82 | Buy |
PRFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.58 | Buy |
| 20-day SMA: | 59.58 | Buy |
| 50-day SMA: | 56.67 | Buy |
| 200-day SMA: | 61.45 | Buy |
| 8-day EMA: | 71.41 | Buy |
| 20-day EMA: | 64.13 | Buy |
| 50-day EMA: | 59.99 | Buy |
| 200-day EMA: | 63.28 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.16 per share.
Perficient Earnings Growth & PRFT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.04 per share, and an increase next year of $0.45 per share.
NovoCure Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perficient Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||